Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Invested Capital (2021 - 2025)

Cytek Biosciences' Return on Invested Capital history spans 5 years, with the latest figure at 0.25% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 19.0% year-over-year to 0.25%; the TTM value through Dec 2025 reached 0.25%, down 19.0%, while the annual FY2025 figure was 0.24%, 19.0% down from the prior year.
  • Return on Invested Capital reached 0.25% in Q4 2025 per CTKB's latest filing, down from 0.07% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2021 to a low of 1.75% in Q1 2021.
  • Average Return on Invested Capital over 5 years is 0.21%, with a median of 0.05% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: skyrocketed 175bps in 2022, then fell -19bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2021, then tumbled by -173bps to 0.01% in 2022, then tumbled by -532bps to 0.05% in 2023, then decreased by -5bps to 0.06% in 2024, then tumbled by -346bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Return on Invested Capital are 0.25% (Q4 2025), 0.07% (Q3 2025), and 0.06% (Q2 2025).